Today it was reported that a Director at Applied DNA Sciences (APDN), Yacov A. Shamash, exercised options to buy 49,165 APDN shares at $0.54 a share, for a total transaction value of $26.55K.
Following this transaction Yacov A. Shamash’s holding in the company was increased by 346.11% to a total of $22.88K. In addition to Yacov A. Shamash, 4 other APDN executives reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Based on Applied DNA Sciences’ latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $2.05 million and GAAP net loss of $1.48 million. In comparison, last year the company earned revenue of $1.02 million and had a GAAP net loss of $2.89 million. Currently, Applied DNA Sciences has an average volume of 473.48K. The company has a one-year high of $1.84 and a one-year low of $0.25.
The insider sentiment on Applied DNA Sciences has been positive according to 10 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion.